BCL2 and acute myeloid leukemia: Moreover, in acute myeloid leukemia (AML) cells, METTL3 was abundantly expressed and promoted MYC, BCL2, and PTEN translation through m6A modification, which inhibited cell differentiation and fueled leukemia progression16.